A big hurdle in the fight against antimicrobial resistance (AMR) is helping Australians to understand how extensive the problem is for the whole population, not just sick people. University of Wollongong molecular microbiologist Associate Professor Martina...
OUTBREAK is a significant opportunity for Australia to lead the global knowledge economy, according to Mimesis Technology chief data scientist and CEO David McCloskey. As a leading figure in social demographics and advanced analytics, Mr McCloskey believes the...
The success of OUTBREAK would put Australia at the forefront of using machine learning to fight antimicrobial resistance (AMR), according to bioinformatician and data scientist Nicole Wheeler from the Centre of Genomic Pathogen Surveillance at the Wellcome Sanger...
Developing the right tools to identify and fight antimicrobial resistance across Australia will use insights from the largest cohort study in the Southern Hemisphere. Analysis of data collected over the past 15 years through the Sax Institute’s 45 and Up Study is set...
OUTBREAK industry partner Microba is a Brisbane-based biotech company that specialises in analysing microbial genomics, specifically – gut bacteria. Dr Ken McGrath is Microba’s Technology Liaison Manager… Q: What is your role with OUTBREAK? My background is...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
